Imugene Ltd: Release of Shares from Voluntary Escrow
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: Notification of cessation of securities - IMU
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: First patient dosed in Phase 1 bile tract cancer trial
Imugene Ltd: Change of Director's Interest Notice x6
Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Imugene Corporate Presentation
Imugene Ltd: Imugene onCARlytics Doses First Patient in IV Combination
Imugene Ltd: Imugene Presentation to Bell Potter Conference
Imugene Ltd: Application for quotation of securities - IMU
Imugene Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Imugene Ltd: Change of Director's Interest Notice - PH
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: Imugene & Kincell Bio Strategic Partnership Investor Webinar
Imugene Ltd: Imugene and Kincell Bio Announce Strategic Partnership
Imugene Ltd: Notification of cessation of securities - IMU
Imugene Ltd: Notification regarding unquoted securities - IMU
Imugene Ltd: Bile Tract Cancer Study Opens after MAST High Dose Clearance
Imugene Ltd: VAXINIA and HER-Vaxx featured at the AACR Annual Meeting
No Data